Mangrove-associated endomycota: diversity and functional significance as a source of novel drug leads

Arch Microbiol. 2023 Oct 3;205(11):349. doi: 10.1007/s00203-023-03679-6.

Abstract

Endophytic fungi are known for their unprecedented ability to produce novel lead compounds of clinical and pharmaceutical importance. This review focuses on the unexplored fungal diversity associated with mangroves, emphasizing their biodiversity, distribution, and methodological approaches targeting isolation, and identification. Also highlights the bioactive compounds reported from the mangrove fungal endophytes. The compounds are categorized according to their reported biological activities including antimicrobial, antioxidant and cytotoxic property. In addition, protein kinase, α-glucosidase, acetylcholinesterase, tyrosinase inhibition, antiangiogenic, DNA-binding affinity, and calcium/potassium channel blocking activity are also reported. Exploration of these endophytes as a source of pharmacologically important compounds will be highly promising in the wake of emerging antibiotic resistance among pathogens. Thus, the aim of this review is to present a detailed report of mangrove derived endophytic fungi and to open an avenue for researchers to discover the possibilities of exploring these hidden mycota in developing novel drug leads.

Keywords: Anticancer; Antimicrobial; Antioxidant; Bioactive compounds; Endophytic fungi; Enzymes; Mangrove.

Publication types

  • Review

MeSH terms

  • Acetylcholinesterase / metabolism
  • Anti-Infective Agents* / pharmacology
  • Antioxidants / metabolism
  • Endophytes
  • Fungi*

Substances

  • Acetylcholinesterase
  • Anti-Infective Agents
  • Antioxidants